Home health ops · Multi-line home care platform
CareVoyant
CareVoyant is a cloud platform for home care and home health agencies. It covers intake, authorization, scheduling, clinical documentation, electronic medication and treatment records (eMAR/eTAR), EVV, and billing across private duty, pediatric private duty nursing (PDN), personal care, home and community-based services (HCBS), and home health on one patient record.
Strong fit
- Agencies running private duty, pediatric private duty nursing, personal care, and home health on one patient record
- Agencies that track lost authorizations, visit verification problems, and claims paid on first submission
- Mid-sized agencies that need electronic medication and treatment records tied to scheduling and billing
Weak fit
- Large post-acute chains that run on big platforms like WellSky or Homecare Homebase
- Buyers who will not bring intake for all their service lines into one system
- Groups that only want a separate visit verification app
Bottom line
CareVoyant is a good fit for home care agencies that run several service lines and want one clinical and billing system for all of them. It suits mid-sized agencies offering private duty, pediatric nursing, community services, and home health. Agencies that want a larger vendor or deeper hospice tools may prefer Axxess.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
CareVoyant's customers are mid-sized home care and home health agencies, especially those running several service lines: private duty, pediatric private duty nursing, home and community-based services, personal care, and home health. All of these share one patient record and one employee record, and intake, authorization, scheduling, documentation, medication and treatment records, electronic visit verification, and billing run in the same system. Pricing is quoted by agency size and modules.
Among the home health operations tools we review, CareVoyant scores 7.0 overall, behind Axxess (7.9), KanTime (7.6), and AxisCare (7.5). Axxess suits agencies that care more about vendor scale and hospice depth, and AxisCare suits agencies whose main need is private-duty scheduling. CareVoyant's case is strongest for agencies with several service lines that want all of them in one system.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Axxess | 7.9 | 7.5 |
| KanTime | 7.6 | 7.3 |
| AxisCare | 7.5 | 7.2 |
| ShiftCare | 7.4 | 7.3 |
| Therap | 7.3 | 7.1 |
| Alora | 7.2 | 7.0 |
| AlayaCare | 7.2 | 6.9 |
| Ankota | 7.2 | 7.3 |
| CareSmartz360 | 7.1 | 6.9 |
| CareVoyant | 7.0 | 6.8 |
| HHAeXchange | 6.9 | 6.6 |
| Careficient | 6.8 | 6.6 |
Pricing
| Item | Detail |
|---|---|
| Model | Cloud software for home care and home health, quoted by agency size and modules. |
| What usually drives cost | The number of users and patients, service lines, how much visit verification you need, and how complex your billing is. |
| What to ask before you buy | The full monthly cost for your patient count and service lines, including visit verification and medication record modules. |
| Published pricing | Quoted for each agency. CareVoyant does not publish prices. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get CareVoyant to function | |
| A list of your service lines and payer authorizations | Authorization rules differ across service lines, and errors there hold up care and payment. |
| Written visit verification rules for each state | The wrong visit verification setup holds up payment. |
| Named clinical and billing leads for the switch | Switches stall when either clinical or billing work has no owner. |
| Clean main lists of patients and employees | Duplicate records cause double bookings and missed visits. |
| Device plan for field clinicians | Point-of-care apps fail without a plan for working offline or staying connected. |
| What will maximize your value | |
| Start with one service line before switching them all | Moving one line at a time limits the damage if something breaks. |
| Measure lost authorizations and claims paid on first submission every week | Those numbers show whether the switch is paying off. |
| Train schedulers on travel time and how caregivers are matched to patients | Bad matches lead to missed visits. |
| Stop old billing exports after one week of running claims in both systems | Billing from two systems at once leads to denials. |
| Confirm medication and treatment record steps with nursing leaders | Errors in medication records can become findings in a state survey. |
| Deal-breakers | |
| You only need a separate visit verification app. | |
| Your service lines and authorization rules are not defined. | |
| No clinical or billing lead owns the switch. | |
| You will not move your main patient lists. | |
| Leaders expect the schedule not to change at all. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | From signing to kickoff | 2-4 weeks |
| 2 | From kickoff to the first service line in use | 8-16 weeks |
| 3 | From the first line to steady results across all lines | 3-6 months |
Recent news
- September 2026: CareVoyant held its 21st virtual user conference and set out plans to add ambient listening for clinical documentation, an AI reader for incoming PDFs and eFaxes, role-based notifications, and an EVV dashboard to its platform.
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.